Curis (CRIS)

• Market cap: $15.9M
• 1 day: -1.6%
• 5 days: -13.99%
• 1 month: -15.17%
• 3 months: -25.45%
• 6 months: -37.24%
• Year to date: -70.99%
• 1 year: -70.15%
• 5 years: -94.92%
• 10 years: -99.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 33